We are live on ! Find out more
SCA

Sippican Capital Advisors Portfolio holdings

AUM $164M
1-Year Est. Return 35.17%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+35.17%
3 Year Est. Return
+90.08%
5 Year Est. Return
+122.79%
10 Year Est. Return
+440.32%
AUM
$105M
AUM Growth
+$8.67M
Cap. Flow
-$3.02M
Cap. Flow %
-2.89%
Top 10 Hldgs %
26.5%
Holding
104
New
5
Increased
21
Reduced
50
Closed
5

Top Buys

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$606K
2
C icon
Citigroup
C
+$262K
3
TRV icon
Travelers Companies
TRV
+$234K
4
TXT icon
Textron
TXT
+$217K
5
TTE icon
TotalEnergies
TTE
+$209K

Top Sells

Rank Stock Value
1
TFIN icon
Triumph Financial Inc
TFIN
+$946K
2
VFC icon
VF Corp
VFC
+$817K
3
DVA icon
DaVita
DVA
+$725K
4
VTRS icon
Viatris
VTRS
+$588K
5
GM icon
General Motors
GM
+$390K

Sector Composition

Rank Sector Weight
1 Healthcare 20.94%
2 Financials 20.62%
3 Energy 17.92%
4 Industrials 13.13%
5 Consumer Discretionary 9.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBBK icon
1
The Bancorp
TBBK
$2.79B
$4.84M 4.63%
170,705
-1,060
-0.6% -$29.3K
CVX icon
2
Chevron
CVX
$388B
$3.63M 3.48%
20,246
-187
-0.9% -$32.6K
ABBV icon
3
AbbVie
ABBV
$458B
$2.67M 2.56%
16,533
-60
-0.4% -$9.2K
NVR icon
4
NVR
NVR
$17.2B
$2.62M 2.51%
568
-5
-0.9% -$22K
MRK icon
5
Merck
MRK
$324B
$2.6M 2.49%
23,438
-631
-3% -$64.5K
COP icon
6
ConocoPhillips
COP
$147B
$2.38M 2.28%
20,175
-775
-4% -$94.2K
PFE icon
7
Pfizer
PFE
$140B
$2.27M 2.17%
44,307
-255
-0.6% -$12.2K
GILD icon
8
Gilead Sciences
GILD
$161B
$2.27M 2.17%
26,419
-2,180
-8% -$173K
BMY icon
9
Bristol-Myers Squibb
BMY
$127B
$2.21M 2.11%
30,659
-152
-0.5% -$11.5K
TRTN
10
DELISTED
Triton International Limited
TRTN
$2.04M 1.95%
29,634
-375
-1% -$23.7K
FANG icon
11
Diamondback Energy
FANG
$57.6B
$1.97M 1.89%
14,425
-166
-1% -$24.3K
PXD
12
DELISTED
Pioneer Natural Resource Co.
PXD
$1.9M 1.82%
8,314
-114
-1% -$27.7K
EOG icon
13
EOG Resources
EOG
$78B
$1.89M 1.81%
14,600
-254
-2% -$33.8K
GE icon
14
GE Aerospace
GE
$367B
$1.87M 1.79%
35,834
-247
-0.7% -$12.1K
MGM icon
15
MGM Resorts International
MGM
$11.7B
$1.78M 1.7%
52,966
-170
-0.3% -$5.89K
LEN icon
16
Lennar Class A
LEN
$20.4B
$1.74M 1.67%
19,911
-209
-1% -$16.9K
CTRA
17
DELISTED
Coterra Energy
CTRA
$1.64M 1.56%
66,533
-445
-0.7% -$12.3K
LLY icon
18
Eli Lilly
LLY
$1.07T
$1.63M 1.56%
4,455
+6
+0.1% +$2.13K
CVS icon
19
CVS Health
CVS
$137B
$1.55M 1.48%
16,605
-192
-1% -$18.5K
DOC
20
DELISTED
PHYSICIANS REALTY TRUST
DOC
$1.54M 1.47%
106,320
+7,295
+7% +$106K
BRK.B icon
21
Berkshire Hathaway Class B
BRK.B
$1.07T
$1.49M 1.42%
4,819
+20
+0.4% +$5.94K
OGN icon
22
Organon & Co
OGN
$3.55B
$1.48M 1.42%
53,090
+2,465
+5% +$63K
XOM icon
23
ExxonMobil
XOM
$651B
$1.47M 1.4%
13,295
-20
-0.2% -$2.14K
MMM icon
24
3M
MMM
$89B
$1.44M 1.38%
14,346
+1,226
+9% +$125K
DIS icon
25
Walt Disney
DIS
$165B
$1.4M 1.34%
16,069
+1,681
+12% +$161K

Similar funds

Sippican Capital Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Sippican Capital Advisors held 104 positions worth $105M, up 9% from $95.9M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Sippican Capital Advisors's Q4 2022 filing shows 5 new, 21 increased, 50 reduced and 5 closed positions. Its largest new stake was T. Rowe Price: 5,359 shares worth $584K. The largest sale was Triumph Financial Inc, an estimated $946K.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Financials and Energy.

  • Sippican Capital Advisors's largest Q4 2022 buy was T. Rowe Price: 5,359 shares worth $584K.
  • Sippican Capital Advisors added most to Citigroup in Q4 2022, an estimated $262K increase.
  • Sippican Capital Advisors's biggest Q4 2022 reduction was Triumph Financial Inc, cutting an estimated $946K.
  • Sippican Capital Advisors fully exited VF Corp in Q4 2022, selling an estimated $817K.
  • Sippican Capital Advisors's ten largest holdings make up 27% of its $105M portfolio in Q4 2022.
  • Sippican Capital Advisors opened 5 new positions and closed 5 in Q4 2022.
  • Sippican Capital Advisors's portfolio value rose 9% quarter-over-quarter to $105M.

Based on Sippican Capital Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.